AI reads CT scans to spot rare kidney cancer before surgery
NCT ID NCT07181954
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed study tested whether a computer model could predict a rare type of kidney cancer (MIT family translocation kidney cancer) from standard CT scans. Researchers analyzed data from 746 patients with kidney cancer, using AI to find patterns in the scans that might indicate this specific cancer type. The goal was to improve diagnosis before surgery, allowing for more personalized treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a new, non-invasive way to identify a rare kidney cancer before surgery, helping doctors choose the best treatment.
What could go wrong
This is a retrospective study, meaning it looks back at existing data. The model needs to be tested in real-time, prospective studies to confirm it works in practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (RCC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.